Florida Senate - 2016 SENATOR AMENDMENT Bill No. SB 460 Ì921638<Î921638 LEGISLATIVE ACTION Senate . House . . . . . ————————————————————————————————————————————————————————————————— ————————————————————————————————————————————————————————————————— Senator Bullard moved the following: 1 Senate Amendment to Amendment (369986) 2 3 Delete lines 298 - 349 4 and insert: 5 from any other plant. At least 75 percent of the cannabis grown 6 must be low-THC cannabis. 7 3. Must inspect seeds and growing plants for plant pests 8 that endanger or threaten the horticultural and agricultural 9 interests of the state, notify the Department of Agriculture and 10 Consumer Services within 10 calendar days after a determination 11 that a plant is infested or infected by such plant pest, and 12 implement and maintain phytosanitary policies and procedures. 13 4. Must perform fumigation or treatment of plants, or the 14 removal and destruction of infested or infected plants, in 15 accordance with chapter 581 and any rule adopted thereunder. 16 (b) When processing low-THC cannabis or medical cannabis, a 17 dispensing organization must: 18 1. Process the low-THC cannabis or medical cannabis within 19 an enclosed structure and in a room separate from other plants 20 or products. At least 75 percent of the cannabis processed must 21 be low-THC cannabis. 22 2. Test the processed low-THC cannabis and medical cannabis 23 before they are dispensed. Results must be verified and signed 24 by two dispensing organization employees. Before dispensing low 25 THC cannabis, the dispensing organization must determine that 26 the test results indicate that the low-THC cannabis meets the 27 definition of low-THC cannabis and, for medical cannabis and 28 low-THC cannabis, that all medical cannabis and low-THC cannabis 29 are safe for human consumption and free from contaminants that 30 are unsafe for human consumption. The dispensing organization 31 must retain records of all testing and samples of each 32 homogenous batch of cannabis and low-THC cannabis for at least 9 33 months. The dispensing organization must contract with an 34 independent testing laboratory to perform audits on the 35 dispensing organization’s standard operating procedures, testing 36 records, and samples and provide the results to the department 37 to confirm that the low-THC cannabis or medical cannabis meets 38 the requirements of this section and that the medical cannabis 39 and low-THC cannabis are safe for human consumption. 40 3. Package the low-THC cannabis or medical cannabis in 41 compliance with the Poison Prevention Packaging Act of 1970, 15 42 U.S.C. ss. 1471 et seq. 43 4. Package the low-THC cannabis or medical cannabis in a 44 receptacle that has a firmly affixed and legible label stating 45 the following information: 46 a. A statement that the low-THC cannabis or medical 47 cannabis meets the requirements of subparagraph 2.; 48 b. The name of the dispensing organization from which the 49 medical cannabis or low-THC cannabis originates; and 50 c. The batch number and harvest number from which the 51 medical cannabis or low-THC cannabis originates. 52 5. Reserve two processed samples from each batch and retain 53 such samples for at least 9 months for the purpose of testing 54 pursuant to the audit required under subparagraph 2. 55 (c) When dispensing low-THC cannabis, medical cannabis, or 56 a cannabis delivery device, a dispensing organization: 57 1. May not dispense more than a 45-day supply of low-THC 58 cannabis or medical cannabis to a patient or the patient’s legal 59 representative, and at least 75 percent of the cannabis 60 dispensed must be low-THC cannabis.